Wells Fargo & Company Guardant Health, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Guardant Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 81,639 shares of GH stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,639
Previous 368,599 77.85%
Holding current value
$2.26 Million
Previous $9.97 Million 83.11%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$17.13 - $26.91 $4.92 Million - $7.72 Million
-286,960 Reduced 77.85%
81,639 $1.68 Million
Q4 2023

Feb 09, 2024
SELL
$21.58 - $29.5 $1.17 Million - $1.6 Million
-54,226 Reduced 12.82%
368,599 $9.97 Million
Q3 2023

Nov 13, 2023
SELL
$25.8 - $39.97 $838,912 - $1.3 Million
-32,516 Reduced 7.14%
422,825 $12.5 Million
Q2 2023

Aug 15, 2023
BUY
$20.94 - $38.01 $1.76 Million - $3.2 Million
84,185 Added 22.68%
455,341 $16.3 Million
Q1 2023

May 12, 2023
BUY
$22.92 - $33.76 $1.03 Million - $1.52 Million
44,878 Added 13.75%
371,156 $8.7 Million
Q4 2022

Feb 13, 2023
SELL
$25.44 - $59.78 $1.6 Million - $3.75 Million
-62,704 Reduced 16.12%
326,278 $8.87 Million
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $1.13 Million - $1.58 Million
25,894 Added 7.13%
388,982 $20.9 Million
Q2 2022

Aug 12, 2022
SELL
$28.82 - $77.35 $189,203 - $507,802
-6,565 Reduced 1.78%
363,088 $14.6 Million
Q1 2022

May 16, 2022
BUY
$48.25 - $100.49 $453,743 - $945,007
9,404 Added 2.61%
369,653 $24.5 Million
Q4 2021

Feb 14, 2022
SELL
$88.71 - $120.43 $85.9 Million - $117 Million
-968,192 Reduced 72.88%
360,249 $36 Million
Q3 2021

Nov 15, 2021
SELL
$98.77 - $132.17 $3.81 Million - $5.1 Million
-38,602 Reduced 2.82%
1,328,441 $166 Million
Q2 2021

Aug 16, 2021
SELL
$109.77 - $165.68 $5.33 Million - $8.04 Million
-48,528 Reduced 3.43%
1,367,043 $170 Million
Q1 2021

May 13, 2021
BUY
$127.04 - $179.1 $4.71 Million - $6.64 Million
37,049 Added 2.69%
1,415,571 $216 Million
Q4 2020

Feb 09, 2021
BUY
$99.96 - $135.93 $12.5 Million - $17 Million
125,153 Added 9.99%
1,378,522 $178 Million
Q3 2020

Nov 05, 2020
BUY
$80.32 - $111.8 $59.7 Million - $83.1 Million
743,619 Added 145.88%
1,253,369 $140 Million
Q2 2020

Aug 13, 2020
SELL
$60.49 - $97.5 $2.19 Million - $3.54 Million
-36,274 Reduced 6.64%
509,750 $41.4 Million
Q1 2020

May 14, 2020
BUY
$59.04 - $88.81 $32.2 Million - $48.5 Million
546,024 New
546,024 $38 Million

Others Institutions Holding GH

# of Institutions
309
Shares Held
110M
Call Options Held
2.51M
Put Options Held
1.7M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.83B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email